debase 发表于 2025-3-25 04:09:33

http://reply.papertrans.cn/2/126/12522/12522-21.png

RODE 发表于 2025-3-25 09:07:44

http://reply.papertrans.cn/2/126/12522/12522-22.png

哥哥喷涌而出 发表于 2025-3-25 14:22:44

http://reply.papertrans.cn/2/126/12522/12522-23.png

Lipoprotein 发表于 2025-3-25 15:58:02

http://reply.papertrans.cn/2/126/12522/12522-24.png

责难 发表于 2025-3-25 20:53:51

Submitted on: 06 July 2006.
Revised on: 23 October 2006.
Accepted on: 06 November 2006.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

conference 发表于 2025-3-26 02:07:41

http://reply.papertrans.cn/2/126/12522/12522-26.png

引起痛苦 发表于 2025-3-26 04:57:53

Submitted on: 11 April 2011.
Revised on: 24 June 2011.
Accepted on: 17 August 2011.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

纵欲 发表于 2025-3-26 11:17:01

http://reply.papertrans.cn/2/126/12522/12522-28.png

严峻考验 发表于 2025-3-26 14:22:44

Submitted on: 29 November 1999.
Revised on: 05 March 2000.
Accepted on: 09 April 2000.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

nuclear-tests 发表于 2025-3-26 19:20:36

http://reply.papertrans.cn/2/126/12522/12522-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊INFLAMMOPHARMACOLOGY 2024/2025影响因子:4.674 (INFLAMMOPHARMACOLOGY) (0925-4692). (TOXICOLOGY)(毒理学)Science Citation In